These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36271003)

  • 1. Antibiotic polymyxin arranges lipopolysaccharide into crystalline structures to solidify the bacterial membrane.
    Manioglu S; Modaresi SM; Ritzmann N; Thoma J; Overall SA; Harms A; Upert G; Luther A; Barnes AB; Obrecht D; Müller DJ; Hiller S
    Nat Commun; 2022 Oct; 13(1):6195. PubMed ID: 36271003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of polymyxin B with lipopolysaccharide-containing membranes.
    Goode A; Yeh V; Bonev BB
    Faraday Discuss; 2021 Dec; 232(0):317-329. PubMed ID: 34550139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the cAMP-cAMP Receptor Protein Regulatory Complex on Lipopolysaccharide Modifications and Polymyxin B Resistance in Escherichia coli.
    Purcell AB; Simpson BW; Trent MS
    J Bacteriol; 2023 May; 205(5):e0006723. PubMed ID: 37070977
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Janet-Maitre M; Job V; Bour M; Robert-Genthon M; Brugière S; Triponney P; Cobessi D; Couté Y; Jeannot K; Attrée I
    mBio; 2024 Mar; 15(3):e0221123. PubMed ID: 38345374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased binding of antibiotics to lipopolysaccharides from polymyxin-resistant strains of Escherichia coli and Salmonella typhimurium.
    Peterson AA; Fesik SW; McGroarty EJ
    Antimicrob Agents Chemother; 1987 Feb; 31(2):230-7. PubMed ID: 3032093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MvfR Controls Tolerance to Polymyxin B by Regulating
    Yang F; Zhou Y; Bai Y; Pan X; Ha UH; Cheng Z; Wu W; Jin Y; Bai F
    Microbiol Spectr; 2023 Jun; 11(3):e0042623. PubMed ID: 37039709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing the effect of polymyxin B antibiotics to lipopolysaccharide on Escherichia coli surface using atomic force microscopy.
    Oh YJ; Plochberger B; Rechberger M; Hinterdorfer P
    J Mol Recognit; 2017 Jun; 30(6):. PubMed ID: 28054415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IS
    Maybin M; Ranade AM; Schombel U; Gisch N; Mamat U; Meredith TC
    mBio; 2024 Jul; 15(7):e0063424. PubMed ID: 38904391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MCR-1 Inhibition with Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Restores Sensitivity to Polymyxin in
    Daly SM; Sturge CR; Felder-Scott CF; Geller BL; Greenberg DE
    mBio; 2017 Nov; 8(6):. PubMed ID: 29114023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of polymyxin B on outer membranes of Serratia marcescens: morphological alterations of the outer membranes and their lipopolysaccharide components.
    Weber DA; Nadakavukaren MJ; Tsang JC
    Microbios; 1976; 17(68-69):149-61. PubMed ID: 200827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymyxins, the last-resort antibiotics: Mode of action, resistance emergence, and potential solutions.
    Mohapatra SS; Dwibedy SK; Padhy I
    J Biosci; 2021; 46(3):. PubMed ID: 34475315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colistin resistance in
    Humphrey M; Larrouy-Maumus GJ; Furniss RCD; Mavridou DAI; Sabnis A; Edwards AM
    Microbiology (Reading); 2021 Nov; 167(11):. PubMed ID: 34723787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of Polymyxin Resistance.
    Moffatt JH; Harper M; Boyce JD
    Adv Exp Med Biol; 2019; 1145():55-71. PubMed ID: 31364071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymyxin Combinations Combat
    Bulman ZP; Chen L; Walsh TJ; Satlin MJ; Qian Y; Bulitta JB; Peloquin CA; Holden PN; Nation RL; Li J; Kreiswirth BN; Tsuji BT
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of dilipid polymyxins: Investigation on the effect of hydrophobicity through its fatty acyl component.
    Domalaon R; Berry L; Tays Q; Zhanel GG; Schweizer F
    Bioorg Chem; 2018 Oct; 80():639-648. PubMed ID: 30053708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The polymyxin derivative NAB739 is synergistic with several antibiotics against polymyxin-resistant strains of Escherichia coli, Klebsiella pneumoniae and Acinetobacter baumannii.
    Tyrrell JM; Aboklaish AF; Walsh TR; Vaara T; Vaara M
    Peptides; 2019 Feb; 112():149-153. PubMed ID: 30586602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Atomic Force Microscopy to Characterize LPS Perturbations.
    Oh YJ
    Methods Mol Biol; 2022; 2548():279-287. PubMed ID: 36151504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance.
    Moore RA; Hancock RE
    Antimicrob Agents Chemother; 1986 Dec; 30(6):923-6. PubMed ID: 3028253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and mechanistic insights into polymyxin resistance mediated by EptC originating from Escherichia coli.
    Zhao Y; Meng Q; Lai Y; Wang L; Zhou D; Dou C; Gu Y; Nie C; Wei Y; Cheng W
    FEBS J; 2019 Feb; 286(4):750-764. PubMed ID: 30537137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.